Position in CABA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,177,000
-$244,000 QoQ
Shares Held
700,000
-22.2% QoQ
Ownership
0.413%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#36
of 139 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CABA Over Time
Shares Held
Position Value (USD)
Derivatives in CABA
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$3,412,000
PutShares
200,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. CABA ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in CABA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,177,000 | 700,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,421,000 | 900,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,971,000 | 900,000 | Shares | Sole | 2026-02-18 | |
| 2024-03-31 | $3,412,000 | 200,000 | Put | Sole | 2024-05-17 | |
| 2023-12-31 | $4,540,000 | 200,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $4,917,274 | 216,620 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $280,145 | 30,286 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $109,604 | 168,623 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,001,096 | 944,431 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $911,470 | 449,000 | Call | Sole | 2022-05-13 | |
| 2022-03-31 | $2,070,742 | 1,020,070 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,603,170 | 423,000 | Call | Sole | 2022-02-14 | |
| 2021-12-31 | $3,677,808 | 970,398 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,444,839 | 1,187,898 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,145,300 | 947,128 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $4,322,162 | 389,384 | Shares | Sole | 2021-08-18 | |
| No filing history on record for this holder in this stock. | ||||||